Profilo
Anthony R.
DiSanto is currently the Vice President of Drug Development at Alamo Pharmaceuticals LLC and the President of AAAgent Services LLC.
He previously worked as a Vice President at The Upjohn Co. He received his undergraduate degree from Philadelphia University and his graduate degree from the University of Michigan.
Posizioni attive di Anthony DiSanto
| Società | Posizione | Inizio |
|---|---|---|
Alamo Pharmaceuticals LLC
 Alamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Alamo Pharmaceuticals LLC markets and develops pharmaceutical products. The company's product FazaClo (clozapine) is used to treat patients with severe schizophrenia. It is also testing the drug in conjunction with schizophrenia treatments to reduce the side effects of anti-psychotic drugs. The company was founded by Neal R. Cutler and is headquartered in Beverly Hills, CA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Anthony DiSanto
| Società | Posizione | Fine |
|---|---|---|
| The Upjohn Co. | Corporate Officer/Principal | - |
Formazione di Anthony DiSanto
| University of Michigan | Graduate Degree |
| Philadelphia University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Alamo Pharmaceuticals LLC
Alamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Alamo Pharmaceuticals LLC markets and develops pharmaceutical products. The company's product FazaClo (clozapine) is used to treat patients with severe schizophrenia. It is also testing the drug in conjunction with schizophrenia treatments to reduce the side effects of anti-psychotic drugs. The company was founded by Neal R. Cutler and is headquartered in Beverly Hills, CA. | Health Technology |
| The Upjohn Co. | Health Technology |
- Borsa valori
- Insiders
- Anthony DiSanto
